Výsledky vyhledávání - "G. Bjelkengren"

Dacarbazine–vindesine versus dacarbazine–vindesine–cisplatin in disseminated malignant melanoma. A randomised phase III trial

Autor: G. Bjelkengren, Jan Mattsson, K. Willman, Ronny Andersson, Per-Uno Malmström, Margareta Karlsson, U. Jungnelius, R. Westberg, Erik Wist, Ulrik Ringborg, Steinar Aamdal, Christian Ingvar, Ulrika Stierner

Publikováno v: European Journal of Cancer. 34:1368-1374

In a multicentre phase III study of disseminated malignant melanoma performed in Sweden and Norway, 326 patients were randomised to receive treatment with the combination dacarbazine [DTIC] (D) and vindesine (V) with or without the addition of cispla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1313036d4fce87d828ac969978549a7f
https://doi.org/10.1016/s0959-8049(98)00068-9

Zobrazit plný text záznamu

Cancer Risk After Iodine-131 Therapy for Hyperthyroidism

Autor: L.-E. Holm, P. Hall, K. Wiklund, G. Lundell, G. Berg, G. Bjelkengren, E. Cederquist, U.-B. Ericsson, A. Hallquist, L.-G. Larsson, M. Lidberg, S. Lindberg, J. Tennvall, H. Wicklund, J. D. Boice

Publikováno v: JNCI Journal of the National Cancer Institute. 83:1072-1077

Cancer incidence was studied in 10,552 patients (mean age, 57 years) who received 131I therapy (mean dose, 506 MBq) for hyperthyroidism between 1950 and 1975. Follow-up on these patients was continued for an average of 15 years. Record linkage with t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4860c2a26549a79f8d7a59bcee1b762
https://doi.org/10.1093/jnci/83.15.1072

Zobrazit plný text záznamu

Oral implant rehabilitation in irradiated patients without adjunctive hyperbaric oxygen

Autor: G, Andersson, L, Andreasson, G, Bjelkengren

Publikováno v: The International journal of oralmaxillofacial implants. 13(5)

In 15 patients treated for malignant tumors in the maxillofacial region, 90 Brånemark implants have been placed in irradiated alveolar bone without adjunctive hyperbaric oxygen therapy. Seventy-eight implants were placed in the mandible and 12 in th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::92358eca148789a8c81112afff0ffbe0
https://pubmed.ncbi.nlm.nih.gov/9796148

Zobrazit plný text záznamu

Determination of a suitable dosage of lysine-vasopressin and triglycyl-lysine-vasopressin, given in a gel-solution locally in the rectum of rats for possible radioprotective purposes

Autor: G. Bjelkengren

Publikováno v: Acta oncologica (Stockholm, Sweden). 29(8)

In order to develop a method for selective radioprotection of the rectal mucosa, a dose-response study was carried out using triglycyl-lysine-vasopressin and lysine-vasopressin. The vasopressin was dissolved in a gel-solution of either Blanose (sodiu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2cc668c9fc8e6a3df0a7c9796270e59
https://pubmed.ncbi.nlm.nih.gov/2278725

Zobrazit plný text záznamu

The Protective Effect of Intra-Arterial Vasopressin Injections on the Small Bowel During Fractionated Abdominal Irradiation A study in pigs

Autor: G. Bjelkengren, Borgström S, K.F. Aronsen, G. Nylander, Lindström C, N.E. Augustsson

Publikováno v: Acta Radiologica: Oncology. 24:401-405

The radioprotective effect of vasopressin-induced intestinal ischemia was investigated in pigs. A bolus injection in the cranial mesenteric artery, of a vasopressin solution, 0.05 IU/kg body weight, was followed by irradiation of the small intestine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b544383dccc2f40fb61aa35a2a225e0
https://doi.org/10.3109/02841868509134408

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání